The Stokes-Adams syndrome.
D000219:Adams-Stokes Syndrome / Q000139:chemically induced / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control / Q000628:therapy; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000503:physiopathology*; D001285:Atropine / Q000627:therapeutic use; D002740:Chlorothiazide / Q000627:therapeutic use; D004071:Digitalis Glycosides / Q000009:adverse effects; D004492:Edetic Acid / Q000627:therapeutic use; D004809:Ephedrine / Q000627:therapeutic use; D004837:Epinephrine / Q000627:therapeutic use; D006327:Heart Block / Q000209:etiology*; D006801:Humans; D007545:Isoproterenol / Q000627:therapeutic use; D007773:Lactates / Q000627:therapeutic use; D008012:Lidocaine / Q000009:adverse effects; D010138:Pacemaker, Artificial / Q000009:adverse effects; D010672:Phenytoin / Q000009:adverse effects; D011343:Procaine / Q000009:adverse effects; D011802:Quinidine / Q000009:adverse effects; D013575:Syncope / Q000209:etiology*; D014882:Water-Electrolyte Balance
D000305:Adrenal Cortex Hormones; D004071:Digitalis Glycosides; D007773:Lactates; D011343:Procaine; D010672:Phenytoin; D002740:Chlorothiazide; D001285:Atropine; D008012:Lidocaine; D004492:Edetic Acid; D004809:Ephedrine; D011802:Quinidine; D007545:Isoproterenol; D004837:Epinephrine